Just Other Articles

Creativity can be defined as problem identification and idea generation whilst innovation can be defined as idea selection,

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

development and commercialisation.

There are other useful definitions in this field, for example, creativity can be defined

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

as consisting of a number of ideas, a number of diverse ideas and a number of novel ideas.

There are distinct processes tha

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

enhance problem identification and idea generation and, similarly, distinct processes that enhance idea selection, developm

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

nt and commercialisation. Whilst there is no sure fire route to commercial success, these processes improve the probability

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

hat good ideas will be generated and selected and that investment in developing and commercialising those ideas will not be

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

asted.

Core Competency and Competitive Advantage

A core competence is one which critically underpins the organisat

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ion's competitive advantage. Companies can differentiate themselves from their competitors with specific core competencies,

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ut often not for long. The differentiation is difficult to sustain and can often be imitated by competitors.

The integratio

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

(and attainment) of constituent skills that is the distinguishing mark of a core competence, is achieved and sustained thro

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

gh developing strong dynamic capabilities, particularly in a world of innovation based competition.

Whilst a core competenc

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

is a source of competitive advantage, not all competitive advantages arise from core competencies. Often seemingly unassai

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

able advantages prove transitory because of a change of underlying factors.

The very existence of competitive advantage set

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

in motion creative innovations that, as competitors strive to level the playing field, cause the advantage to dissipate.

R

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ecognition of, and adaptation, to change is thus a pre-requisite of successful strategy. For many organisations, the only tr

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ly sustainable advantage comes from out-innovating the competition.

These and other topics are covered in depth in the MBA

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

issertation on Managing Creativity & Innovation, which can be purchased (along with a Creativity and Innovation DIY Audit, G

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

od Idea Generator Software and Power Point Presentation) from ht

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

p://www.managing-creativity.com/

You can also receive a regular, free newsletter by entering your email address at this

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

site.

You are free to reproduce this article as long as no changes are made and the author's name and site URL are retained

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/24222/justotherarticles-Business-Innovation--Core-Competency-and-Competitive-Advantage.html">Business Innovation - Core Competency and Competitive Advantage</a>

BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/24222/justotherarticles-Business-Innovation--Core-Competency-and-Competitive-Advantage.html]Business Innovation - Core Competency and Competitive Advantage[/url]

Instability in the Middle East and threats to geo political harmony from Iran are combining to hike up oil prices around the world. This is having an impact at all levels from big business to consumers; and the freight industry in particular is under strain as a result.

A corporations or an LLC can choose to be treated as an S corporation for Federal tax purposes. Electing to be treated as an S corporation allows income to flow through the corporation without being taxed until it is claimed as income by the shareholders. If you are considering whether to elect to be treated as an S corporation, there are certain IRS limitations that you should discuss with your accountant.

For the first time in modern history, the workforce will encompass four separate generations working side by side. The Silent Generation (born 1933-1945), Baby Boomers (born 1946-1964), Generation Xers (born 1965-1976), and Generation Yers (born 1977-1998).

Tags

Links

Just Other Articles - Business Innovation - Core Competency and Competitive Advantage

Related Articles: